A Year After I Stopped Taking a Weight-Loss Drug, I’ve Lost 20 More Pounds.
I’m one of the millions of people trying to keep the weight off without taking expensive drugs like Mounjaro or Ozempic for ...
pharmaphorum15h
GSK bags breakthrough status for bone cancer drug
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
pharmaphorum15h
Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn
A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...